Hexvix®, A Diagnostic Drug of Asieris, is Now Covered by the 2022 Lecheng Global Specialty Drug Insurance

/PRNewswire/ -- Asieris Pharmaceuticals (688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs...

Related Keywords

Lecheng ,Hainan ,China ,Norway ,Taiwan ,Shanghai ,United States ,Oslo ,Chinese ,Xinming Jiang ,Security Bureau Of Hainan Province ,Hainan Office Of China Banking ,Chinese Urological Association Guideline ,Prnewswire Asieris Pharmaceuticals ,Asieris Pharmaceuticals ,National Medical Products Administration ,Insurance Regulatory Commission ,Global Specialty Drug Insurance ,Hainan Office ,China Banking ,Medical Security Bureau ,Chinese Urological Association ,Hainan Province ,Hainan General Hospital ,Specialty Drug ,Vice President ,Asieris ,